{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T13:37:55Z","timestamp":1782135475657,"version":"3.54.5"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.atherosclerosis.2018.03.031","type":"journal-article","created":{"date-parts":[[2018,3,18]],"date-time":"2018-03-18T20:43:46Z","timestamp":1521405826000},"page":"101-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Elevated serum uric acid levels are associated with endothelial dysfunction in HIV patients receiving highly-active antiretroviral therapy"],"prefix":"10.1016","volume":"272","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5527-4821","authenticated-orcid":false,"given":"Matteo","family":"Pirro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Bianconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3216-4144","authenticated-orcid":false,"given":"Elisabetta","family":"Schiaroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Francisci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo R.","family":"Mannarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bagaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Merriman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7993-1059","authenticated-orcid":false,"given":"Franco","family":"Baldelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib1","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1080\/15257770802138558","article-title":"Uric acid: the oxidant-antioxidant paradox","volume":"27","author":"Sautin","year":"2008","journal-title":"Nucleos Nucleot. Nucleic Acids"},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s40200-015-0200-z","article-title":"Association between serum uric acid level and metabolic syndrome components","volume":"14","author":"Nejatinamini","year":"2015","journal-title":"J.\u00a0Diabetes. Metab. Disord"},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib3","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/127596","article-title":"Relationship between hyperuricemia and lipid profiles in US adults","volume":"2015","author":"Peng","year":"2015","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib4","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.2169\/internalmedicine.46.0045","article-title":"Relationship between hyperuricemia and body fat distribution","volume":"46","author":"Hikita","year":"2007","journal-title":"Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s12603-016-0749-3","article-title":"The role of uric acid for predicting future metabolic syndrome and type 2 diabetes in older people","volume":"21","author":"Chang","year":"2017","journal-title":"J.\u00a0Nutr. Health Aging"},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib6","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.amjcard.2004.06.032","article-title":"Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk","volume":"94","author":"Mercuro","year":"2004","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib7","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1161\/CIRCULATIONAHA.106.651117","article-title":"High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid","volume":"114","author":"George","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib8","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005957","article-title":"A\u00a0higher baseline plasma uric acid level is an independent predictor of arterial stiffness: a community-based prospective study","volume":"96","author":"Ding","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib9","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.2169\/internalmedicine.54.4310","article-title":"The effects of allopurinol on the carotid intima-media thickness in patients with type 2 diabetes and asymptomatic hyperuricemia: a three-year randomized parallel-controlled study","volume":"54","author":"Liu","year":"2015","journal-title":"Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib10","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1681\/ASN.2005050572","article-title":"Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells","volume":"16","author":"Kang","year":"2005","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib11","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/micc.12200","article-title":"High concentrations of uric acid inhibit endothelial cell migration via miR-663 which regulates phosphatase and tensin homolog by targeting transforming growth factor-\u03b21","volume":"22","author":"Hong","year":"2015","journal-title":"Microcirculation"},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib12","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3892\/ijmm.2016.2491","article-title":"Uric acid enhances PKC-dependent eNOS phosphorylation and mediates cellular ER stress: a mechanism for uric acid-induced endothelial dysfunction","volume":"37","author":"Li","year":"2016","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib13","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/1755-5922.12215","article-title":"Allopurinol therapy improves vascular endothelial function in subjects at risk for cardiovascular diseases: a meta-analysis of randomized controlled trials","volume":"34","author":"Xin","year":"2016","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib14","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.2337\/db06-0283","article-title":"Uric acid restores endothelial function in patients with type 1 diabetes and regular smokers","volume":"55","author":"Waring","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/toxins9010020","article-title":"High uric acid ameliorates indoxyl sulfate-induced endothelial dysfunction and is associated with lower mortality among hemodialysis patients","volume":"9","author":"Hsu","year":"2017","journal-title":"Toxins"},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib16","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1161\/HYPERTENSIONAHA.116.08488","article-title":"Effect of uric acid-lowering agents on endothelial function: a randomized, double-blind, placebo-controlled trial","volume":"69","author":"Borgi","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib17","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1253\/circj.CJ-14-1267","article-title":"Depletion of uric acid due to SLC22A12 (URAT1) loss-of-function mutation causes endothelial dysfunction in hypouricemia","volume":"79","author":"Sugihara","year":"2015","journal-title":"Circ. J."},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib18","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1007\/s00125-007-0817-7","article-title":"Lowering serum urate does not improve endothelial function in patients with type 2 diabetes","volume":"50","author":"Waring","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib19","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1001\/jama.283.18.2404","article-title":"Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey","volume":"283","author":"Fang","year":"2000","journal-title":"J.\u00a0Am. Med. Assoc."},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.atherosclerosis.2016.10.006","article-title":"Elevated serum uric acid and risk of cardiovascular or all-cause mortality in people with suspected or definite coronary artery disease: a meta-analysis","volume":"254","author":"Wang","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib21","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1681\/ASN.2014070660","article-title":"Uric acid and cardiovascular events: a mendelian randomization study","volume":"26","author":"Kleber","year":"2015","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib22","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s12872-016-0421-1","article-title":"Asymptomatic hyperuricemia is not an independent risk factor for cardiovascular events or overall mortality in the general population of the Busselton Health Study","volume":"16","author":"Nossent","year":"2016","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib23","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f4262","article-title":"Association of plasma uric acid with ischaemic heart disease and blood pressure: mendelian randomisation analysis of two large cohorts","volume":"347","author":"Palmer","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib24","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jacc.2015.10.086","article-title":"Causal assessment of serum urate levels in cardiometabolic diseases through a mendelian randomization study","volume":"67","author":"Keenan","year":"2016","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib25","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S2213-8587(15)00386-1","article-title":"Plasma urate concentration and risk of coronary heart disease: a Mendelian randomisation analysis","volume":"4","author":"White","year":"2016","journal-title":"Lancet. Diabetes. Endocrinol"},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib26","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.amjmed.2015.11.003","article-title":"Effect of allopurinol on cardiovascular outcomes in hyperuricemic patients: a cohort study","volume":"129","author":"Larsen","year":"2016","journal-title":"Am. J. Med."},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib27","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/HYPERTENSIONAHA.115.06344","article-title":"Allopurinol and cardiovascular outcomes in adults with hypertension","volume":"67","author":"MacIsaac","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib28","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.2215\/CJN.01580210","article-title":"Effect of allopurinol in chronic kidney disease progression and cardiovascular risk","volume":"5","author":"Goicoechea","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib29","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nrrheum.2016.102","article-title":"Insight into rheumatological cause and effect through the use of Mendelian randomization","volume":"12","author":"Robinson","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib30","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2014-000174","article-title":"Cardiovascular disease in HIV patients: from bench to bedside and backwards","volume":"2","author":"Cerrato","year":"2015","journal-title":"Open. Heart"},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/srep28741","article-title":"Urinary albumin-to-creatinine ratio is associated with endothelial dysfunction in HIV-infected patients receiving antiretroviral therapy","volume":"6","author":"Pirro","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2337\/dc06-1075","volume":"30","author":"Samaras","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib33","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2337\/diacare.25.7.1253","article-title":"Prevalence of metabolic syndrome among HIV patients","volume":"25","author":"Gazzaruso","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib34","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1097\/01.aids.0000237374.16068.de","article-title":"High serum urate in HIV-infected persons: the choice of the antiretroviral drug matters","volume":"20","author":"Walker","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib35","first-page":"2","article-title":"Hyperuricemia, its prevalence and correlation with metabolic syndrome in anti-retroviral naive HIV cohort: review of the literature","volume":"2","author":"Patel","year":"2013","journal-title":"J.\u00a0Immunol. Tech. Infect. Dis"},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib36","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/17571472.2017.1302872","article-title":"Human immunodeficiency virus and type 2 diabetes","volume":"9","author":"Avari","year":"2017","journal-title":"Lond. J. Prim. Care (Abingdon)"},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib37","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11904-016-0330-z","article-title":"Metabolic complications and glucose metabolism in HIV infection: a review of the evidence, curr","volume":"13","author":"Willig","year":"2016","journal-title":"HIV\/AIDS Rep"},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib38","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jacl.2016.12.003","article-title":"JCL roundtable: managing lipid disorders in patients with HIV","volume":"11","author":"Brown","year":"2017","journal-title":"J.\u00a0Clin. Lipidol"},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib39","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1210\/jc.2004-1273","article-title":"Antiretroviral treatment reduces very-low-density lipoprotein and intermediate-density lipoprotein apolipoprotein B fractional catabolic rate in human immunodeficiency virus-infected patients with mild dyslipidemia","volume":"90","author":"Shahmanesh","year":"2005","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib40","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/jac\/dkl190","article-title":"Endothelial function in HIV-infected patients with low or mild cardiovascular risk","volume":"58","author":"Blanco","year":"2006","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib41","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jacc.2008.04.049","article-title":"Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: the ACTG (AIDS Clinical Trials Group) Study 5152s","volume":"52","author":"Torriani","year":"2008","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib42","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1001\/archinte.166.8.909","article-title":"Prognostic impact of prolonged ventricular repolarization in hypertension","volume":"166","author":"Schillaci","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib43","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an american heart association\/national heart, lung, and blood institute scientific statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib44","first-page":"277","article-title":"Prevalence of metabolic syndrome in patients with HIV in the era of highly active antiretroviral therapy","volume":"79","author":"Lombo","year":"2015","journal-title":"Conn. Med."},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib45","doi-asserted-by":"crossref","first-page":"474","DOI":"10.2337\/dc08-1394","article-title":"Presence of the metabolic syndrome is not a better predictor of cardiovascular disease than the sum of its components in HIV-infected individuals: data collection on adverse events of anti-HIV drugs (D: a:D) study","volume":"32","author":"Worm","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib46","first-page":"1295","article-title":"Is it time to revise the normal range of serum uric acid levels?","volume":"18","author":"Desideri","year":"2014","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib47","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/qjmed\/hct083","article-title":"Independent and conjoint associations of gout and hyperuricaemia with total and cardiovascular mortality","volume":"106","author":"Stack","year":"2013","journal-title":"QJM"},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib48","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nature05488","article-title":"Abdominal obesity and metabolic syndrome","volume":"444","author":"Despr\u00e9s","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib49","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1517\/14728222.2012.723694","article-title":"The uric acid metabolism pathway as a therapeutic target in hyperuricemia related to metabolic syndrome","volume":"16","author":"Sim\u00e3o","year":"2012","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib50","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.bbrc.2014.04.080","article-title":"High uric acid directly inhibits insulin signalling and induces insulin resistance","volume":"447","author":"Zhu","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143786","article-title":"Uric acid levels can predict metabolic syndrome and hypertension in adolescents: a 10-year longitudinal study","volume":"10","author":"Sun","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib52","doi-asserted-by":"crossref","first-page":"8603164","DOI":"10.1155\/2016\/8603164","article-title":"Role of uric acid metabolism-related inflammation in the pathogenesis of metabolic syndrome components such as atherosclerosis and nonalcoholic steatohepatitis","volume":"2016","author":"Kushiyama","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib53","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1086\/516616","article-title":"Metabolic syndrome and subclinical atherosclerosis in patients infected with HIV","volume":"44","author":"Mangili","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib54","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S1726-4901(09)70320-X","article-title":"Association between serum uric acid level and components of the metabolic syndrome","volume":"69","author":"Lin","year":"2006","journal-title":"J.\u00a0Chin. Med. Assoc."},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib55","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.numecd.2009.08.006","article-title":"Endothelial dysfunction in metabolic syndrome: prevalence, pathogenesis and management","volume":"20","author":"Tziomalos","year":"2010","journal-title":"Nutr. Metabol. Cardiovasc. Dis."},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib56","doi-asserted-by":"crossref","first-page":"69S","DOI":"10.1177\/0003319708320761","article-title":"Endothelial injury and repair: a novel theory for atherosclerosis","volume":"59","author":"Mannarino","year":"2008","journal-title":"Angiology"},{"key":"10.1016\/j.atherosclerosis.2018.03.031_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5049\/EBP.2014.12.1.1","article-title":"Uric acid puzzle: dual role as anti-oxidantand pro-oxidant","volume":"12","author":"Kang","year":"2014","journal-title":"Electrolyte Blood. Press."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191501830159X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002191501830159X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,12]],"date-time":"2019-10-12T23:08:18Z","timestamp":1570921698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002191501830159X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":57,"alternative-id":["S002191501830159X"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.03.031","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated serum uric acid levels are associated with endothelial dysfunction in HIV patients receiving highly-active antiretroviral therapy","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.03.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}